147 related articles for article (PubMed ID: 27334278)
1. Sustained distribution of aerosolized PEGylated liposomes in epithelial lining fluids on alveolar surfaces.
Kaneko K; Togami K; Yamamoto E; Wang S; Morimoto K; Itagaki S; Chono S
Drug Deliv Transl Res; 2016 Oct; 6(5):565-71. PubMed ID: 27334278
[TBL] [Abstract][Full Text] [Related]
2. Effect of surface-mannose modification on aerosolized liposomal delivery to alveolar macrophages.
Chono S; Kaneko K; Yamamoto E; Togami K; Morimoto K
Drug Dev Ind Pharm; 2010 Jan; 36(1):102-7. PubMed ID: 19656002
[TBL] [Abstract][Full Text] [Related]
3. Prolonged distribution of aerosolized PEGylated liposomes in the lungs of mice with bleomycin-induced pulmonary fibrosis.
Togami K; Maruta Y; Nanbu M; Tada H; Chono S
Drug Dev Ind Pharm; 2020 Nov; 46(11):1873-1880. PubMed ID: 32940095
[TBL] [Abstract][Full Text] [Related]
4. Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification.
Chono S; Tanino T; Seki T; Morimoto K
J Pharm Pharmacol; 2007 Jan; 59(1):75-80. PubMed ID: 17227623
[TBL] [Abstract][Full Text] [Related]
5. Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages.
Togami K; Chono S; Morimoto K
Biopharm Drug Dispos; 2011 Oct; 32(7):389-97. PubMed ID: 21812004
[TBL] [Abstract][Full Text] [Related]
6. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
Togami K; Chono S; Morimoto K
J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):110-5. PubMed ID: 22360316
[TBL] [Abstract][Full Text] [Related]
7. Aerosol-based efficient delivery of telithromycin, a ketolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
Togami K; Chono S; Seki T; Morimoto K
Drug Dev Ind Pharm; 2010 Jul; 36(7):861-6. PubMed ID: 20515406
[TBL] [Abstract][Full Text] [Related]
8. Efficient drug delivery to alveolar macrophages and lung epithelial lining fluid following pulmonary administration of liposomal ciprofloxacin in rats with pneumonia and estimation of its antibacterial effects.
Chono S; Tanino T; Seki T; Morimoto K
Drug Dev Ind Pharm; 2008 Oct; 34(10):1090-6. PubMed ID: 18777242
[TBL] [Abstract][Full Text] [Related]
9. Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages.
Vyas SP; Quraishi S; Gupta S; Jaganathan KS
Int J Pharm; 2005 May; 296(1-2):12-25. PubMed ID: 15885451
[TBL] [Abstract][Full Text] [Related]
10. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages.
Vyas SP; Kannan ME; Jain S; Mishra V; Singh P
Int J Pharm; 2004 Jan; 269(1):37-49. PubMed ID: 14698575
[TBL] [Abstract][Full Text] [Related]
11. Efficient drug delivery to lung epithelial lining fluid by aerosolization of ciprofloxacin incorporated into PEGylated liposomes for treatment of respiratory infections.
Chono S; Suzuki H; Togami K; Morimoto K
Drug Dev Ind Pharm; 2011 Apr; 37(4):367-72. PubMed ID: 20815792
[TBL] [Abstract][Full Text] [Related]
12. Distribution characteristics of telithromycin, a novel ketolide antimicrobial agent applied for treatment of respiratory infection, in lung epithelial lining fluid and alveolar macrophages.
Togami K; Chono S; Seki T; Morimoto K
Drug Metab Pharmacokinet; 2009; 24(5):411-7. PubMed ID: 19881252
[TBL] [Abstract][Full Text] [Related]
13. [Intrapulmonary Pharmacokinetics and Drug Distribution Characteristics for the Treatment of Respiratory Diseases].
Togami K
Yakugaku Zasshi; 2020; 140(3):345-354. PubMed ID: 32115551
[TBL] [Abstract][Full Text] [Related]
14. Influence of particle size on drug delivery to rat alveolar macrophages following pulmonary administration of ciprofloxacin incorporated into liposomes.
Chono S; Tanino T; Seki T; Morimoto K
J Drug Target; 2006 Sep; 14(8):557-66. PubMed ID: 17043040
[TBL] [Abstract][Full Text] [Related]
15. Liposomal Aerosols of Nitric Oxide (NO) Donor as a Long-Acting Substitute for the Ultra-Short-Acting Inhaled NO in the Treatment of PAH.
Nahar K; Rashid J; Absar S; Al-Saikhan FI; Ahsan F
Pharm Res; 2016 Jul; 33(7):1696-710. PubMed ID: 27048347
[TBL] [Abstract][Full Text] [Related]
16. [Designs of optimized microbial therapy systems of respiratory infections].
Morimoto K
Yakugaku Zasshi; 2013; 133(1):81-92. PubMed ID: 23292024
[TBL] [Abstract][Full Text] [Related]
17. Aerosol-based efficient delivery of azithromycin to alveolar macrophages for treatment of respiratory infections.
Togami K; Chono S; Morimoto K
Pharm Dev Technol; 2013; 18(6):1361-5. PubMed ID: 22812381
[TBL] [Abstract][Full Text] [Related]
18. Inhaled pyrazinamide proliposome for targeting alveolar macrophages.
Rojanarat W; Nakpheng T; Thawithong E; Yanyium N; Srichana T
Drug Deliv; 2012; 19(7):334-45. PubMed ID: 22985352
[TBL] [Abstract][Full Text] [Related]
19. PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation.
Shavi GV; Sreenivasa Reddy M; Raghavendra R; Nayak UY; Kumar AR; Deshpande PB; Udupa N; Behl G; Dave V; Kushwaha K
J Liposome Res; 2016; 26(1):28-46. PubMed ID: 25853340
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary delivery of insulin by liposomal carriers.
Huang YY; Wang CH
J Control Release; 2006 Jun; 113(1):9-14. PubMed ID: 16730838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
